Alkohol, alkoholisme

Alkoholavhengighet

Alkohol

Pasientinformasjon

Rus- og avhengighetsmedisin

Kliniske kapitler

Håndboken

Norsk Elektronisk Legehåndbok

Hva er alkoholavhengighet?

Hva kjennetegner en alkoholavhengig?

Råd til den alkoholavhengiges partner

Hva kan skadelig bruk av alkohol føre til?

Kroppslige sykdommer knyttet til skadelig bruk av alkohol

Psykiske tilstander knyttet til alkoholavhengighet

Hva kan en gjøre?

Vil du vite mer?

Skj&oslash;tskift S. Alkohol som medvirkende faktor i noen vanlige kliniske situasjoner. Tidsskr Nor L&aelig;geforen 2003; 123: 185-7. 

--&gt; https://fhi.no/nettpub/hin/psykisk-helse/ruslidelser/

Folkehelserapporten. Rusbrukslidelser i Norge. Folkehelseinstituttet, oppdatert 06.12.2019. 

O`Dowd. Alcohol accounts for 6% of all admissions til English hospitals. BMJ 2008; 337: a963. 

Tolstrup JS, Nordestgaard BG, Rasmussen S, Tybj&aelig;rg-Hansen A, Gr&oslash;nb&aelig;k M. Genetisk variation i alkoholdehydrogenase, alkoholdrikkevaner og alkoholisme - sekund&aelig;rpublikation. Ugeskr L&aelig;ger 2008; 170: 2672. 

--&gt; http://dx.doi.org/10.1073/pnas.1611243113

Schumann G, Liu C, O'Reilly P, et al. KLB is associated with alcohol drinking, and its gene product &beta;-Klotho is necessary for FGF21 regulation of alcohol preference. Proc Natl Acad Sci USA 2016; 113:14372. doi: 10.1073/pnas.1611243113 

--&gt; http://dx.doi.org/10.4045/tidsskr.22.0449

Tvedt H, Stokke R, Lid TH, Selbekk AS. Problematisk alkoholbruk etter fedmekirurgi &ndash; en kvalitativ studie. Tidsskr Nor Legeforen 2023. doi:10.4045/tidsskr.22.0449 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29072781[uid]

Torvik FA, Ystrom E, Gustavson K, et al. Diagnostic and genetic overlap of three common mental disorders in structured interviews and health registries. Acta Psychiatr Scand. 2018 Jan;137(1):54-64. PMID: 29072781. 

Brown RL, Saunders LA, Bobula JA, Lauster MH. Remission of alcohol disorders in primary care patients. J Fam Pract 2000; 49: 522-8. 

Braut GS. Krav til rusmiddelarbeid i helsetenesta. Tidsskr Nor L&aelig;geforen 2003; 123: 49-51. 

Nordlie E. Alkoholmisbruk - hvilke konsekvenser har det for familiemedlemmene?. Tidsskr Nor L&aelig;geforen 2003; 123: 52-4. 

Winslow BT, Onysko M. Medications for alcohol use disorder. Am Fam Physician. 2016 Mar 15;93(6):457-465. 

Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings. A systematic review and meta-analysis. JAMA 2014; 311: 1889-900. doi:10.1001/jama.2014.3628. 

Pettinati HM, Oslin DW, Kampman KM, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occuring depression and alcohol dependence. Am J Psychiatry 2010; 167: 668-75. 

Pani PP, Trogu E, Pacini M, et al. Anticonvulsants for alcohol dependence. Cochrane Database Syst Rev. 2014 Feb 13;2:CD008544. 

Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002; 17: 349-55. 

Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial . Lancet 2003; 361: 1677-85. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=36001306[uid]

Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial. JAMA Psychiatry 2022; 79: 953-962. pmid:36001306 

--&gt; http://dx.doi.org/10.1002/14651858.CD001867.pub3

R&ouml;sner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD001867. DOI: 10.1002/14651858.CD001867.pub3. 

Carmen B, et al. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004; 99: 811-28. 

Berglund M, Thelander S, Salaspuro M et al. Treatment of alcohol abuse: An evidence-based review. Alcohol Clin Exp Res 2003; 27: 1645-56. 

Journal of the American Medical Association

Anton RF, O&rsquo;Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE Study: a randomized controlled trial. JAMA 2006; 295: 2003-17. 

Bouza C, Magro A, Munoz A, Amate J. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004; 99: 811-8. 

--&gt; http://dx.doi.org/10.1371/journal.pmed.1001924

Palpacuer C, Laviolle B, Boussageon R, et al. Risks and benefits of nalmefene in the treatment of adult alcohol dependence: A systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials. PLoS Med. 2015. doi: 10.1371/journal.pmed.1001924 

M&oslash;rland J. Legemidler mot alkoholmisbruk. Tidsskr Nor L&aelig;geforen 2006; 126: 3268-9. 

Heilig M, Egli M. Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms. Pharmacol Ther 2006; 111: 855-76. 

Rosner S, Hackl-Herrwerth A, Leucht S, et al. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010; 9: CD004332. 

Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings. A Systematic Review and Meta-analysis. JAMA. 2014 14;311(18):1889-900. doi: 10.1001/jama.2014.3628. 

Mann K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence in alcohol dependent individuals: Results of a metaanalysis. Alcohol Clin Exp Res 2004; 28: 51-63. 

Namkoong K, Lee BQ, Lee PG et al. Acamprosate in Korean alcohol-dependent patients: A multi-centre, randomized, double-blind, placebo controlled study. Alcohol Alcohol 2003; 28: 135 - 41. 

Johnson BA, Rosenthal N, Capece JA, et al, for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007; 298: 1641-51. 

Mason BJ, Quello S, Goodell V, et al. Gabapentin treatment for alcohol dependence: A randomized clinical trial. JAMA Intern Med 2013. doi:10.1001/jamainternmed.2013.11950 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=37000449[uid]

Zhao J, Stockwell T, Naimi T, et al. Association Between Daily Alcohol Intake and Risk of All-Cause Mortality A Systematic Review and Meta-analyses. JAMA Netw Open 2023; 6: e236185. pmid:PMID: 37000449 

Foster T. Editorial. Dying for a drink. BMJ 2001; 323: 817-8. 

--&gt; http://dx.doi.org/10.1001/jamanetworkopen.2022.39485

Esser MB, Leung G, Sherk A, et al. Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019. JAMA Netw Open 2022. doi:10.1001/jamanetworkopen.2022.39485 